Topoisomerase II inhibitors, together with mitoxantrone, are associated with the development of secondary acute myeloid leukemia and myelosuppression. Drug Interactions Mitoxantrone and its metabolites are excreted in bile and urine, but It isn't known whether or not the metabolic or excretory pathways are saturable, may very well be inhibited or https://waltery009phz0.ourcodeblog.com/profile